MedTrace Logo

Investigation of Chronic Obstructive Pulmonary Disease (COPD) Phenotypes and Endotypes in China

NCT04853225 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2005

Last updated 2025-08-20

Study results available
· View outcomes & findings →

Summary

This is a non-drug interventional cohort study, which aims to investigate the clinical, radiological and biological factors associated with disease progression in COPD in China. Participants will be recruited from multiple hospitals across Guangdong province categorized as Type A hospitals (those at prefecture-level and above) and Type B hospitals (those below prefecture-level).

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

OTHER

Prospective observational cohort study

Prospective observational cohort study

Sponsors & Collaborators

  • Guangzhou Institute of Respiratory Health (GIRH)

    collaborator UNKNOWN

  • GlaxoSmithKline

    lead INDUSTRY

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-22
Primary Completion
2024-06-25
Completion
2024-06-25

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04853225 on ClinicalTrials.gov